![Chip Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chip Clark
Voorzitter bij
IBIO, INC.
Vermogen: 3 492 $ op 31-05-2026
Profiel
William D.
Clark was the founder of Vanda Pharmaceuticals, Inc., founded in 2002, where the titles held included Secretary, Chief Business Officer & Senior VP from 2003 to 2010.
Mr. Clark was the founder of Vibrant Biomedicines, founded in 2024, serving as President & Chief Executive Officer from 2024 to 2025.
Current jobs include Chief Executive Officer at Altido Therapeutics, Inc. starting in 2026, Chairman at iBio, Inc. starting in 2022, and Independent Director at Aldeyra Therapeutics, Inc. starting in 2025.
Former jobs include President, Chief Executive Officer & Director at Genocea Biosciences, Inc. from 2011 to 2022, Independent Director at Arsanis, Inc. from 2017 to 2019, Principal at Care Capital LLC from 2004 to 2005, and Head-Business Development at GlaxoSmithKline LLC.
Education includes undergraduate studies at Harvard University and an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IBIO, INC. 0,01% | 20-11-2025 | 1.838 ( 0,01% ) | 3 492 $ | 31-05-2026 |
Actieve functies van Chip Clark
| Bedrijven | Functie | Begin |
|---|---|---|
| IBIO, INC. | Voorzitter | 01-11-2022 |
| ALDEYRA THERAPEUTICS, INC. | Directeur/Bestuurslid | 17-04-2025 |
Eerdere bekende functies van Chip Clark
| Bedrijven | Functie | Einde |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Algemeen Directeur | 01-01-2022 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Directeur/Bestuurslid | 13-03-2019 |
| VANDA PHARMACEUTICALS INC. | Oprichter | 26-03-2010 |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million. | Private Equity Investor | 20-06-2005 |
Opleiding van Chip Clark
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
51
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Care Capital LLC
Care Capital LLC Investment ManagersFinance Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million. | Finance |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
